A. Butt

发表

BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation

R. Sutherland, L. Anderson, A. Butt, 2010, Oncogene.

Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer

Margaret Gardiner-Garden, Robert L. Sutherland, Mark Pinese, 2008, PloS one.

IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells.

R. Baxter, A. Butt, K. A. Fraley, 2002, Endocrinology.

Overcoming resistance: Targeting the PI3K/mTOR pathway in endocrine refractory breast cancer

A. Butt, 2011, Cancer biology & therapy.

Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism

R. Sutherland, A. Butt, T. Biden, 2007, Molecular Cancer Therapeutics.

Butyrate- but not TGFβ1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatase

C. Paraskeva, A. Butt, A. Hague, 1997, Cell Death and Differentiation.

Synthesis and in vitro evaluation of analogues of avocado-produced toxin (+)-(R)-persin in human breast cancer cells.

W. Denny, R. Sutherland, D. G. Brooke, 2011, Bioorganic & medicinal chemistry.

Identification of downstream targets of estrogen and c-myc in breast cancer cells.

R. Sutherland, E. Musgrove, C. McNeil, 2008, Advances in experimental medicine and biology.

Estrogens, Cell Proliferation and Breast Cancer

R. Sutherland, E. Musgrove, C. McNeil, 2008 .

Microtubule-stabilizing properties of the avocado-derived toxins (+)-(R)-persin and (+)-(R)-tetrahydropersin in cancer cells and activity of related synthetic analogs

W. Denny, J. Miller, D. G. Brooke, 2016, Investigational New Drugs.

Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo*

R. Baxter, A. Butt, Kristie-Ann Dickson, 2003, Journal of Biological Chemistry.

Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling.

R. Baxter, A. Butt, Janet L Martin, 2004, The Journal of clinical endocrinology and metabolism.

Dimerization and Autoprocessing of the Nedd2 (Caspase-2) Precursor Requires both the Prodomain and the Carboxyl-terminal Regions*

Sharad Kumar, A. Butt, N. Harvey, 1998, The Journal of Biological Chemistry.

Departing is such sweet sorrow

H. Beere, A. Butt, A. Moore, 1998, Cell Death and Differentiation.

A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells

R. Sutherland, C. K. Watts, A. Butt, 2006, Molecular Cancer Therapeutics.

Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells*

M. King, R. Baxter, A. Butt, 2000, The Journal of Biological Chemistry.

The IGF axis and programmed cell death

R. Baxter, A. Butt, S. Firth, 1999, Immunology and cell biology.

Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer

S. O'toole, R. Sutherland, E. Musgrove, 2011, Oncogene.

Cell cycle machinery: links with genesis and treatment of breast cancer.

R. Sutherland, E. Musgrove, C. McNeil, 2008, Advances in experimental medicine and biology.

Review of: Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis

A. Butt, 2005 .

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast

A. Biankin, S. O'toole, R. Sutherland, 2008, British Journal of Cancer.

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome

A. Biankin, T. Preiss, R. Sutherland, 2008, Breast Cancer Research.

Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.

Robert L Sutherland, R. Sutherland, E. Musgrove, 2005, Endocrine-related cancer.

Functional Activation of Nedd2/ICH-1 (Caspase-2) Is an Early Process in Apoptosis*

Sharad Kumar, A. Butt, N. Harvey, 1997, The Journal of Biological Chemistry.

Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-β (TGF-β) and the Type II TGF-β Receptor*

R. Baxter, A. Butt, S. Fanayan, 2000, The Journal of Biological Chemistry.

IGFBP-3 and apoptosis—a licence to kill?

A. Williams, A. Butt, A. Williams, 2001, Apoptosis.

The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis?

C. Paraskeva, A. Butt, A. Hague, 1996, Proceedings of the Nutrition Society.

Loss of apc protein expressed by human colonic epithelial cells and the appearance of a specific low‐molecular‐weight form is associated with apoptosis IN vitro

C. Paraskeva, A. Butt, A. Hague, 1994, International journal of cancer.

Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells.

R. Baxter, A. Butt, Kristie-Ann Dickson, 2005, Endocrinology.

Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p 53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells *

M. King, R. Baxter, A. Butt, 2000 .

Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells.

C. Paraskeva, A. Williams, A. Butt, 2003, Carcinogenesis.

Global characterization of signalling networks associated with tamoxifen resistance in breast cancer

Naveid A Ali, R. Nicholson, R. Linding, 2013, The FEBS journal.

c-Myc overexpression and endocrine resistance in breast cancer

Margaret Gardiner-Garden, Robert L. Sutherland, James G. Kench, 2006, The Journal of Steroid Biochemistry and Molecular Biology.

Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.

R. Baxter, A. Butt, S. Fanayan, 2000, The Journal of biological chemistry.

Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3.

R. Baxter, A. Butt, L. Schedlich, 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells

R. Nicholson, R. Sutherland, E. Musgrove, 2013, British Journal of Cancer.

Live or let die: oestrogen regulation of survival signalling in endocrine response

R. Sutherland, E. Musgrove, A. Butt, 2007, Breast Cancer Research.

Register4: an Australian web‐enabled resource created by the National Breast Cancer Foundation to facilitate and accelerate cancer research

C. Apicella, A. Butt, J. Hopper, 2014, Medical Journal of Australia.

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome

A. Biankin, T. Preiss, R. Sutherland, 2008, Breast Cancer Research.

Evaluation of the impact of National Breast Cancer Foundation‐funded research

C. Donovan, A. Butt, S. Hanney, 2014, The Medical journal of Australia.

Predicting response: identifying molecular determinants of endocrine response and resistance in breast cancer

A. Butt, 2011, Expert review of endocrinology & metabolism.